Trends in the Cumulative Post-Marketing Reporting Rates of Retinal Vasculitis and/or Retinal Vascular Occlusion and Associated Vision Loss with Brolucizumab

por Igwe, Franklin, Lodha, Amit, Ravindran, Arun
Publicado 2022

The Treatment Patterns with Brolucizumab in Germany (REALIZE) Study: A Retrospective Cohort Study Based on Longitudinal Prescription Data

por Liegl, Raffael G., Karcher, Helene, Chetty-Mhlanga, Shala, Igwe, Franklin, Freitas, Rita
Publicado 2022

Resource Use and Real-World Outcomes for Ranibizumab Treat and Extend for Neovascular Age-Related Macular Degeneration in the UK: Interim Results from TERRA

por Yang, Yit, Downey, Louise, Mehta, Hemal, Mushtaq, Bushra, Narendran, Niro, Patel, Nishal, Patel, Praveen J., Ayan, Filis, Gibson, Kara, Igwe, Franklin, Jeffery, Pete
Publicado 2017

Potential for Treatment Interval Extension in Eyes with nAMD Disease Activity Post Loading Phase in HAWK and HARRIER

por Tadayoni, Ramin, Jaffe, Glenn J., Holz, Frank G., Schmidt-Erfurth, Ursula, Takahashi, Kanji, Cheung, Chui Ming Gemmy, Hariprasad, Seenu M., Gedif, Kinfemichael, Olsen, Rasmus, Best, Catherine, Igwe, Franklin, Kaiser, Peter K.
Publicado 2023

Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study

por Gale, Richard P, Pearce, Ian, Eter, Nicole, Ghanchi, Faruque, Holz, Frank G, Schmitz-Valckenberg, Steffen, Balaskas, Konstantinos, Burton, Ben J L, Downes, Susan M, Eleftheriadis, Haralabos, George, Sheena, Gilmour, David, Hamilton, Robin, Lotery, Andrew J, Patel, Nishal, Prakash, Priya, Santiago, Cynthia, Thomas, Saju, Varma, Deepali, Walters, Gavin, Williams, Michael, Wolf, Armin, Zakri, Rosina H, Igwe, Franklin, Ayan, Filis
Publicado 2020